XML 21 R8.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Statement of Cash Flows [Abstract]    
Net income $ 403,805 $ 393,035
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation expense 194,167 198,175
Depreciation 54,635 66,915
Impairments and amortization of intangibles 29,897 63,409
Deferred income taxes 35,161 5,223
Other adjustments, net 15,507 5,553
Changes in assets and liabilities    
Accounts receivable (16,450) (41,412)
Other assets 43,803 4,968
Accounts payable and other liabilities 36,572 403
Income taxes payable and receivable (31,118) 11,387
Deferred revenue (8,379) (29,647)
Net cash provided by operating activities 757,600 678,009
Cash flows from investing activities:    
Capital expenditures (42,100) (43,011)
Other, net (25,783) (8,061)
Net cash used in investing activities (67,883) (51,072)
Cash flows from financing activities:    
Proceeds from Senior Notes offerings 700,000 0
Principal payments on Term Loan (425,000) 0
Payments to settle exchangeable notes (74,437) 0
Debt issuance costs (8,619) 0
Proceeds from issuance of common stock pursuant to stock-based awards 3,598 9,411
Withholding taxes paid on behalf of employees on net settled stock-based awards (115,619) (11,430)
Purchase of treasury stock (549,905) (630,623)
Dividends (140,893) 0
Purchase of noncontrolling interests (84) (1,291)
Other, net (6,225) (2,193)
Net cash used in financing activities (617,184) (636,126)
Total cash provided (used) 72,533 (9,189)
Effect of exchange rate changes on cash and cash equivalents 14,714 2,281
Net increase (decrease) in cash and cash equivalents 87,247 (6,908)
Cash and cash equivalents at beginning of period 965,993 862,440
Cash and cash equivalents at end of period $ 1,053,240 $ 855,532